Maxwell Biosciences

Maxwell Bioscience’s technology was discovered using an artificial intelligence analysis of the proteomics of vulnerability in aging. AI makes it clear that many of the symptoms of aging are driven by the gradual weakening of the immune system – called immunosenescence. This discovery allows us to not only extend healthspan and potentially reverse aspects of aging, but to also help stabilize civilization against previously untreatable infectious pathogens. Maxwell’s world-first “One drug for MANY bugs” approach is a new way to fight infectious disease, bolster the immune system and prevent age-related diseases.